Background Neurocognitive impairment (NCI) in people with human immunodeficiency virus
(PWH) remains a concern despite potent antiretroviral therapy (ART). Higher central nervous …

Background The objective of our study was to compare two different central nervous system
penetration-effectiveness (CPE) scores for the prediction of cognitive dysfunction in HIV …

Introduction Central nervous system (CNS) penetration‐effectiveness (CPE) rank was
proposed in 2008 as an estimate of penetration of ARV regimen into the CNS, and validated …

Background: Cognitive impairment can occur or persist during antiretroviral therapy (ART).
Explanations include comorbidities, neurotoxic ART, persistent neuroinflammation, or …

This literature review summarizes the existing research examining the CNS penetration
effectiveness (CPE) score and neurocognitive outcomes (ie, neuropsychological …

Objectives The aim of the study was to examine baseline neurocognitive impairment (NCI)
prevalence and factors associated with NCI among patients enrolled in the Neurocognitive …

Background The aim of the study was to explore how viral resistance and antiretroviral
central nervous system (CNS) penetration could impact on cognitive performance of HIV …

Objectives Diagnosing neurocognitive impairment (NCI) in HIV infection requires time‐
consuming neuropsychological assessment. Screening tools are needed to identify when …

Objective: To assess changes over time in neuropsychological test results (NPr) and risk
factors among a regularly followed HIV-infected patient population. Methods: Prospective …

Background There are limited data on the comparative prevalence of neurocognitive
impairment (NCI) in aging people living with human immunodeficiency virus (PLHIV) and …